uniQure N.V. (0EE0.L)

USD 16.7

(1.06%)

Eps Summary of uniQure N.V.

  • uniQure N.V.'s latest annual eps in 2023 was -6.47 USD , down -138.75% from previous year.
  • uniQure N.V.'s latest quarterly eps in 2024 Q3 was -0.91 USD , up 21.55% from previous quarter.
  • uniQure N.V. reported an annual eps of -2.71 USD in 2022, down -137.8% from previous year.
  • uniQure N.V. reported an annual eps of 7.17 USD in 2021, up 355.16% from previous year.
  • uniQure N.V. reported a quarterly eps of -1.36 USD for 2024 Q1, up 11.11% from previous quarter.
  • uniQure N.V. reported a quarterly eps of -1.16 USD for 2024 Q2, up 14.71% from previous quarter.

Annual Eps Chart of uniQure N.V. (2023 - 2011)

Historical Annual Eps of uniQure N.V. (2023 - 2011)

Year Eps Eps Growth
2023 -6.47 USD -138.75%
2022 -2.71 USD -137.8%
2021 7.17 USD 355.16%
2020 -2.81 USD 12.19%
2019 -3.20 USD -36.75%
2018 -2.34 USD 21.48%
2017 -2.98 USD -1.71%
2016 -2.93 USD 17.23%
2015 -3.54 USD -34.6%
2014 -2.63 USD -25.24%
2013 -2.10 USD -89.19%
2012 -1.11 USD 12.6%
2011 -1.27 USD 0.0%

Peer Eps Comparison of uniQure N.V.

Name Eps Eps Difference
Editas Medicine, Inc. -2.02 USD -220.297%
Dynavax Technologies Corporation -0.05 USD -12944.355%
Supernus Pharmaceuticals, Inc. 0.02 USD 26946.473%
Perrigo Company plc -0.09 USD -6790.309%
Illumina, Inc. -7.35 USD 11.973%
Thermo Fisher Scientific Inc. 15.53 USD 141.661%
Iovance Biotherapeutics, Inc. -1.89 USD -242.328%
Walgreens Boots Alliance, Inc. -10.01 USD 35.365%
IQVIA Holdings Inc. 7.39 USD 187.551%
Heron Therapeutics, Inc. -0.80 USD -708.75%
Regeneron Pharmaceuticals, Inc. 37.05 USD 117.463%
Unity Biotechnology, Inc. -2.70 USD -139.63%
Waters Corporation 10.87 USD 159.522%
Biogen Inc. 8.02 USD 180.673%
Sangamo Therapeutics, Inc. -1.48 USD -337.162%
Evolus, Inc. -1.08 USD -499.074%
Adicet Bio, Inc. -3.31 USD -95.468%
Cara Therapeutics, Inc. -2.19 USD -195.434%
bluebird bio, Inc. -1.93 USD -235.233%
Esperion Therapeutics, Inc. -2.03 USD -218.719%
FibroGen, Inc. -2.92 USD -121.575%
Agilent Technologies, Inc. 4.22 USD 253.318%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 37.245%
Homology Medicines, Inc. -7.41 USD 12.686%
Geron Corporation -0.32 USD -1921.875%
Alnylam Pharmaceuticals, Inc. -3.52 USD -83.807%
Amicus Therapeutics, Inc. -0.51 USD -1168.627%
Myriad Genetics, Inc. -1.39 USD -365.468%
Viking Therapeutics, Inc. -0.91 USD -610.989%
Intellia Therapeutics, Inc. -5.42 USD -19.373%
Zoetis Inc. 5.08 USD 227.362%
Abeona Therapeutics Inc. -2.53 USD -155.731%
Mettler-Toledo International Inc. 36.10 USD 117.922%
BioMarin Pharmaceutical Inc. 0.89 USD 826.966%
Vertex Pharmaceuticals Incorporated 14.05 USD 146.05%
Kala Pharmaceuticals, Inc. -17.35 USD 62.709%
Ionis Pharmaceuticals, Inc. -2.56 USD -152.734%
Atara Biotherapeutics, Inc. -65.18 USD 90.074%
Verastem, Inc. -3.96 USD -63.384%
Nektar Therapeutics -1.45 USD -346.207%
Axsome Therapeutics, Inc. -5.27 USD -22.77%
Aclaris Therapeutics, Inc. -1.27 USD -409.449%
Sarepta Therapeutics, Inc. -5.80 USD -11.552%
OPKO Health, Inc. -0.25 USD -2488.0%
Exelixis, Inc. 0.65 USD 1095.385%
Neurocrine Biosciences, Inc. 2.56 USD 352.734%
Corcept Therapeutics Incorporated 1.02 USD 734.314%
Anavex Life Sciences Corp. -0.60 USD -978.333%
Imunon, Inc. -2.16 USD -199.537%
Blueprint Medicines Corporation -8.37 USD 22.7%
Insmed Incorporated -5.34 USD -21.161%
Halozyme Therapeutics, Inc. 2.13 USD 403.756%
Agios Pharmaceuticals, Inc. -6.33 USD -2.212%
TG Therapeutics, Inc. 0.09 USD 7345.241%
Incyte Corporation 2.67 USD 342.322%
Emergent BioSolutions Inc. -14.85 USD 56.431%